Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals
1998 FOUNDED
PUBLIC STATUS
501-600 EMPLOYEES
IRWD STOCK SYMBOL
$12.53 SHARE PRICE (As of Tuesday Closing)
Description

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 301 Binney Street
  • Cambridge, MA 02142
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ironwood Pharmaceuticals’s full profile, request a free trial.

Ironwood Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$7.91 - $14.10 $1.96B $12.60 -$0.27 1.72M 157M

Ironwood Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,676,718 1,843,962 2,415,765 2,290,617
Revenue 432,804 346,639 298,276 273,957
EBITDA (25,173) (233,412) (68,061) (32,464)
Net Income (41,846) (282,368) (116,937) (81,708)
Total Assets 334,343 332,050 605,674 709,821
Total Debt 435,269 413,923 400,168 372,801
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ironwood Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Ironwood Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Ironwood Pharmaceuticals Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Samumed Private Equity-Backed San Diego, CA 000 00000 0000000 0000 00000
000000 Formerly VC-backed San Diego, CA 00 000000&0
000000000 000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
00000000 00000 Formerly VC-backed Leiden, Netherlands 000 00000 000000000 00000
000000 000000000 Formerly Angel backed Brooklyn, NY 00 00.000 00000000 00.000
To view this company’s complete list of competitors, request access »

Ironwood Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Ironwood Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Ironwood Pharmaceuticals Executive Team (21)

Name Title Board
Seat
Contact
Info
Mark Currie Ph.D Chief Scientific Officer & President
Thomas McCourt President
Gina Consylman Chief Financial Officer & Senior Vice President
Halley Gilbert JD Chief Administrative Officer & Senior Vice President
Christopher Wright Ph.D Chief Development Officer & Senior Vice President of Global Development

4 Former Executives

You’re viewing 5 of 21 executives. Get the full list »

Ironwood Pharmaceuticals Board Members (14)

Name Representing Role Since Contact
Info
000 00000000 00 Self Board Member 000 0000
00000000 0000000 00.0 Self Board Member, Advisory Team 000 0000
0000000 00000000 00.0 Self Board Member 000 0000
000000 00000 Self Board Member 000 0000
00000 000000 Self Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 14 board members. Get the full list »